Alpha 2.0
Login Register
» Articles » PMID: 33707958

Renal Involvement in COVID-19: A Review of the Literature

Overview
Journal Infect Drug Resist
Publisher Dove Medical Press
Date 2021 Mar 12
PMID 33707958
Citations 16
Authors
Marco Giuseppe Migliaccio
Marco Di Mauro
Riccardo Ricciolino
Giorgio Spiniello
Vincenzo Carfora
Nicoletta Verde
Filiberto Fausto Mottola
Nicola Coppola
Affiliations
Soon will be listed here.
Abstract

Kidney injury may be a severe complication of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and contributes to worsen the prognosis. Various pathophysiological mechanisms can contribute to organ damage and impair renal function, proving the complexity of the virus activity and the resulting immunity response. We summarized the evidence of the literature on the prevalence of kidney involvement, on the pathogenic pathways and on its management.

Citing Articles

Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage.

Chang Y, Wei A PLoS One. 2024; 19(1):e0297664.

PMID: 38295140 PMC: 10830027. DOI: 10.1371/journal.pone.0297664.

Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target.

Luo D, Lu X, Li Y, Xu Y, Zhou Y, Mao H Kidney Dis (Basel). 2023; 9(6):469-484.

PMID: 38089440 PMC: 10712987. DOI: 10.1159/000533296.

Factors associated with acute kidney injury (AKI) and mortality in COVID-19 patients in a Sub-Saharan African intensive care unit: a single-center prospective study.

Nlandu Y, Makulo J, Essig M, Sumaili E, Lumaka A, Engole Y Ren Fail. 2023; 45(2):2263583.

PMID: 37870858 PMC: 11001370. DOI: 10.1080/0886022X.2023.2263583.

Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study.

Russo A, Pisaturo M, Monari C, Ciminelli F, Maggi P, Allegorico E Pathogens. 2023; 12(8).

PMID: 37623933 PMC: 10459783. DOI: 10.3390/pathogens12080973.

Association between the severity of periodontitis, COVID-19, C-reactive protein and interleukin-6 levels in hospitalized patients: a case‒control study.

Moradi Haghgoo J, Torkzaban P, Farhadian M, Moosavi Sedeh S BMC Oral Health. 2023; 23(1):556.

PMID: 37568161 PMC: 10422752. DOI: 10.1186/s12903-023-03270-x.

References
1.
Libby P, Simon D . Inflammation and thrombosis: the clot thickens. Circulation. 2001; 103(13):1718-20. DOI: 10.1161/01.cir.103.13.1718. View
2.
Zhang C, Wu Z, Li J, Zhao H, Wang G . Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954. PMC: 7118634. DOI: 10.1016/j.ijantimicag.2020.105954. View
3.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View
4.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View
5.
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo F, Chong M . Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020; 323(16):1612-1614. PMC: 7082763. DOI: 10.1001/jama.2020.4326. View